The Kidney Donation Anti-Discrimination Act prohibits life insurance underwriters from treating someone differently solely because they have donated a kidney. It applies to all aspects of policy interaction, including offering, issuing, cancellation, pricing, terms, or the amount of coverage, provided there is no evidence of actuarial risk unrelated to the donation.
The bill also creates a private right of action allowing an injured donor to sue in federal court for damages and attorney’s fees. Finally, it preserves any state or local laws that offer greater protections than this act and provides precise definitions for key terms.
At a Glance
What It Does
It makes discrimination against living kidney donors in life-insurance underwriting unlawful, covering offers, issuances, cancellations, pricing, and coverage amounts unless actuarial risks unrelated to donation are demonstrated.
Who It Affects
Directly affects life insurance carriers, underwriters, and individuals who have donated a kidney or may donate in the future.
Why It Matters
Establishes a federal floor for donor protections, reducing barriers to insurability post-donation and aligning underwriting practice with medical realities of living donation.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
This bill stops life insurers from denying or altering policies simply because someone has donated a kidney. It blocks discrimination in every stage of policy interaction—from initial offers to the terms of coverage and how much coverage is provided—unless there is actuarial risk that is unrelated to the donation.
It empowers individuals who believe they were treated unfairly to sue the insurer in federal court and seek damages and legal fees. The act does not override stronger state or local protections, and it includes clear definitions of what counts as a life insurance policy and who qualifies as a living kidney donor.
Together, these provisions aim to preserve donors’ access to life insurance while maintaining room for states to strengthen protections if they choose.
The Five Things You Need to Know
The bill forbids discrimination against living kidney donors in life-insurance underwriting.
Discrimination is prohibited in offering, issuance, cancellation, pricing, or coverage terms.
There is a private right of action in federal court for damages and attorney’s fees.
States may maintain stricter protections; the act does not preempt them.
Definitions for key terms (life insurance policy; living kidney donor) are established.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Discrimination Prohibition Based on Donor Status
It shall be unlawful to discriminate against a living kidney donor in the offering, issuance, cancellation, price, or conditions of a life insurance policy, or in the amount of coverage, based solely on donor status. No discrimination may occur without evidence of actuarial risks unrelated to donation, ensuring that donation itself cannot be used as a pricing lever.
Private Right of Action
A person harmed by a violation may sue the discriminating entity in the appropriate federal district court for damages and attorney’s fees. This provides an enforceable remedy and a clear path for recourse beyond administrative actions.
Non-Preemption of State/Local Law
Nothing in this section preempts state or local laws that provide greater protections to living kidney donors regarding life insurance. This preserves and respects a spectrum of existing protections while establishing a federal baseline.
Definitions
Definitions for “life insurance policy” and “living kidney donor” anchor the bill’s scope. A life insurance policy is a contract to pay a designated beneficiary upon the insured’s death, and a living kidney donor is an individual who has donated a kidney and is not deceased.
This bill is one of many.
Codify tracks hundreds of bills on Finance across all five countries.
Explore Finance in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Living kidney donors receive protection from underwriting bias that could affect insurability after donation.
- Prospective kidney donors gain confidence that a donation won’t jeopardize future life-insurance access.
- Transplant programs and donor-support organizations can point to a clearer, federally backed standard.
- Insurance regulators gain a uniform baseline for underwriting practices across states.
- Consumer advocacy groups focused on health equity benefit from stronger nondiscrimination protections.
Who Bears the Cost
- Life insurers must adjust underwriting guidelines, pricing models, and training to comply with the new standard.
- Insurance brokers and agents incur costs to implement compliant processes and educate clients.
- Federal courts may see an uptick in private actions, creating docket and resource implications for the judiciary.
Key Issues
The Core Tension
The central dilemma is whether prohibiting use of donor status in underwriting can be harmonized with actuarial pricing practices. Donor protections must be robust enough to remove discrimination while insurers retain the ability to assess genuinely unrelated risk; resolving this tension will determine how easily the bill translates into practice and how it affects insurability for donors in the real world.
The bill seeks to balance nondiscrimination with insurers’ need to price risk. The practical challenge lies in defining what constitutes an “additional actuarial risk unrelated to donation”—a standard that will require careful underwriting interpretation and may become a focal point of disputes.
The private suit remedy heightens enforcement visibility but could also lead to increase in litigation funding and claims activity, particularly if state courts are asked to interpret the standard differently. The non-preemption clause helps ensure states can go further if they wish, but it also raises questions about consistency of underwriting standards across jurisdictions.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.